Skip to main content

Table 5 Associations of confirmed or highly suspicious SARS-CoV-2 infection. Multivariable analysis

From: Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis

 

OR

95% CI

p

 Disease duration ≥ 120 months

0.71

0.50 to 0.99

0.04

 Home lockdown

1.02

0.64 to 1.60

0.94

 PDN

1.23

1.04 to 1.44

0.02

 csDMARDs

0.89

0.55 to 1.43

0.62

 b/tsDMARDs

0.47

0.46 to 0.48

< 0.001

 AUC 0.62

   
  1. PDN prednisone, csDMARDs conventional synthetic disease-modifying anti-rheumatic drugs, b/ts DMARDs biological/targeted synthetic disease-modifying anti-rheumatic drugs. Highly suspicious infection: respiratory symptoms + contacts with COVID-19 cases
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us